Mebanazine

Mebanazine is a pharmaceutical drug that belongs to the class of antipsychotic medications. It was developed in the mid-20th century and has been used in the treatment of various mental disorders.

History

Mebanazine was first synthesized in the 1950s as part of a series of compounds designed to treat psychosis. It was one of the first antipsychotic drugs to be developed, following the discovery of chlorpromazine in the early 1950s.

Pharmacology

Mebanazine works by blocking dopamine receptors in the brain. Dopamine is a neurotransmitter that plays a key role in mood, motivation, and reward. By blocking these receptors, Mebanazine can help to reduce the symptoms of psychosis.

Clinical Use

Mebanazine has been used in the treatment of a variety of mental disorders, including schizophrenia, bipolar disorder, and severe depression. It is typically used in cases where other treatments have been ineffective.

Side Effects

Like all antipsychotic drugs, Mebanazine can cause a range of side effects. These can include drowsiness, dizziness, and blurred vision. In rare cases, it can also cause more serious side effects such as tardive dyskinesia, a condition characterized by involuntary movements of the face and body.

See Also

• Antipsychotic
• Dopamine
• Schizophrenia
• Bipolar disorder
• Depression

References

‎

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian